Tookad-Soluble + VTP effective and safe in treatment of low-risk prostate cancer

Another new media report (based on data just published in Lancet Oncology) states that “vascular-targeted photodynamic therapy” or VTP in combination with an experimental drug called padeliporfin or WST11 can be used to successfully treat low-risk prostate cancer. … READ MORE …

New trial of VTP for localized prostate cancer opens at five US centers

A media release from New York University Langone Medical Center, issued yesterday, has announced the initiation of a multi-center, Phase I/II clinical trial of vascular-targeted photodynamic therapy (VTP) in men with localized prostate cancer. … READ MORE …